The Goldilocks Principle: Optimal Antithrombotic Strategies in the Cardiac ICU

Posted on December 31, 2023
Robert J. DiDomenico, PharmD, FCCP, FHFSA, FACC, Alissa Shega, PharmD, BCCP, and Patrick M. Wieruszewski, PharmD, BCCCP

Authors:
Robert J. DiDomenico, PharmD, FCCP, FHFSA, FACC
Associate Professor
Assistant Head, Faculty Affairs & Strategic Initiatives
Department of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy
Clinical Pharmacist
UI Health

Alissa Shega, PharmD, BCCP
Clinical Pharmacist – Cardiac Intensive Care Unit
Rush University Medical Center

Patrick M. Wieruszewski, PharmD, BCCCP
Assistant Professor of Anesthesiology
Assistant Professor of Pharmacy
Cardiothoracic Surgery & ECMO Program
Mayo Clinic


Disclosure(s):
Dr. Alissa Shega has no relevant financial conflicts of interest in relation to this activity. Dr. Robert DiDomenico, a speaker, is a consultant for PhaseBio Pharmaceuticals, Inc and received grant/research support from CSL Behring. Dr. Patrick Wieruszewski, a speaker, is a consultant for La Jolla Pharmaceutical Company. All of the relevant financial relationships listed for this individual have been mitigated. The reviewers who contributed to this activity have nothing to disclose.

Type of Activity: Knowledge-based

Learning Objectives:

  • Review the pharmacology of bivalirudin and alternative parenteral anticoagulants used to treat acute coronary syndrome (ACS).
  • Review the safety and efficacy of bivalirudin and other parenteral anticoagulants for the treatment of ACS.
  • Discuss updates in the management of purge solution for patients receiving Impella® support.
  • Discuss pharmacologic strategies for maintenance anticoagulation during extracorporeal membrane oxygenation (ECMO).
Target Audience: Pharmacists Fee: $10 (or $90 for all 10 courses). For C4 2023 participants who registered for the live program, please use the access code provided to you by email.
Release Date: May 16, 2023 Expiration Date: September 25, 2025
Estimated Time to Complete: 1 hour CE: 1.0 contact hours (0.1 CEUs)

Go to activity

acpe
The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been assigned ACPE Universal Activity Number 0016-0000-23-046-H01-P, for 1.0 contact hours (0.1 CEUs). Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test and activity evaluation; estimating duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

How to Earn Credit:

Participants must complete the activity as described above in the Continuing Education Statement. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on ‘Finish Attempt’, then click on ‘Submit All and Finish’ at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test, a confirmation message will appear at the top of the page underneath your grade. You will have a chance to review the correct answers and answer rationale.

Hardware/Software and Internet Requirements can be found at https://pharmacyce.uic.edu/moodle/.

Provider Contact Information:
For general information or questions,  email the Office of Continuing Education and Meeting Services at pharmce@uic.edu. Copyright © 2023– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

Modified on January 20, 2024